Basic Information
ID: ALA4324504
Type: Functional
Description: Anti-inflammatory activity in mBSA/CFA-immunized Lewis rat delayed-type hypersensitivity model assessed as reduction in ear swelling at 1 to 15 mg/kg, po via gavage administered twice daily for 2 days treated prior to mBSA/CFA challenge measured after up to 50 hrs
Format: BAO_0000218
Organism: Rattus norvegicus
Strain: Lewis
Target: Rattus norvegicus(ALA376)
Document: ALA4321852
Anti-inflammatory activity in mBSA/CFA-immunized Lewis rat delayed-type hypersensitivity model assessed as reduction in ear swelling at 1 to 15 mg/kg, po via gavage administered twice daily for 2 days treated prior to mBSA/CFA challenge measured after up to 50 hrs: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4324504
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 514.38 | 6.26 | 6.26 |